Healthy Home News

A study in the British Journal of Cancer found that the risk of death from breast cancer was 42% lower in women with high vitamin D levels, compared to those with low levels.

Federal vaccine advisors today approved a third booster dose of Pfizer-BioNTech's COVID-19 vaccine on an emergency use basis, but only for the most vulnerable groups, which includes those age 65 and older and people at high risk of severe disease.

A new study led by researchers with the Centers for Disease Control and Prevention (CDC) indicates that strains of extensively drug-resistant (XDR) bacteria linked to pet store puppies have been circulating for a decade and continue to cause illness.

The New Mexico Department of Health (NMDOH) has identified five cases of West Nile Virus infections in residents of Bernalillo, Doña Ana, and Taos County. This year, no West Nile Virus deaths have been reported.

U.S. health authorities plan to spend $2.1 billion to improve infection prevention and control across American health care, by far the largest single such outlay in the country’s history.

Around 12,000 people have contracted dengue fever in the district of Firozabad alone, resulting in more than 110 deaths

Russian President Vladimir Putin said on Thursday morning that "not just one or two but several dozen people" from his inner circle had contracted coronavirus.

A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.

Men diagnosed with low- to intermediate-risk prostate cancer — meaning cancers that are less likely to cause problems over time, even if left untreated — face a difficult choice: should they undergo immediate treatment, or should they be monitored with active surveillance and be treated only if the cancer shows evidence of progression?

All three COVID-19 vaccines currently in use in the United States offer significant protection against hospitalization for COVID-19, but Moderna is the most effective among US adults who are not immunocompromised, according to new data published today in Morbidity and Mortality Weekly Report.